IP Library Granted Patent US 7,867,521
Granted Patent B2
US 7,867,521 · App. 11/574,635 · Granted Jan 11, 2011

Aspartame and citrate flavored phosphate salt laxative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,867,521
App. No.
11/574,635
Granted
Jan 11, 2011
Kind
B2
Abstract

The present invention provides compositions, kits, and methods suitable for cleansing the colon before colonoscopy. The compositions include a phosphate salt and a flavorant that includes aspartame and a citrate. The kits include the previously mentioned compositions and also may include suitable containers, packaging, relief wipes, and instructions for use. The methods may include administering orally to a subject an aqueous preparation including monobasic sodium phosphate, dibasic sodium phosphate, aspartame, and citric acid.

Claims (14)

1. A composition for colonic cleansing comprising:

a flavorant comprising aspartame, maltodextrin, acesulfame potassium, and a citrate; and

a phosphate salt comprising from 0.4 to 1 gram/mL of monobasic sodium phosphate and from 0.13 to 0.25 gram/mL of dibasic sodium phosphate, where about 45 mL of the phosphate salt is combined with 2.0 g+/−10% by weight of the flavorant.

2. A kit for colonic cleansing, comprising the composition of claim 1 .

3. A method for colonic cleaning, comprising:

administering to a subject in need thereof the composition of claim 1 , wherein the subject experiences less abdominal cramping and less anal irritation when compared to an otherwise identical composition except that the flavorant consists of cola flavor.

4. The composition of claim 1 , where the composition further comprises a flavoring selected from the group consisting of natural fruit flavors, artificial fruit flavors, and combinations thereof.

5. The composition of claim 1 , where the phosphate salt is present as a liquid comprising water and 0.48 gram/mL of monobasic sodium phosphate and 0.18 gram/mL of dibasic sodium phosphate.

6. The composition of claim 1 , further comprising ascorbic acid or a salt thereof.

7. The kit of claim 2 , where the flavorant further comprises a flavoring selected from the group consisting of natural fruit flavors, artificial fruit flavors, and combinations thereof.

8. The kit of claim 2 , further comprising ascorbic acid or a salt thereof.

9. The kit of claim 2 , further comprising at least one anorectal wipe, the anorectal wipe wetted with an aqueous solution including a local anesthetic and a skin protectant.

10. The method of claim 3 , where the composition further comprises ascorbic acid or a salt thereof.

11. The method of claim 3 , further comprising administering oral re-hydration liquids to the subject.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 27, 2017
From: GOLUB CAPITAL MARKETS LLC (F/K/A GCI CAPITAL MARKETS LLC)
To: C. B. FLEET COMPANY, INC.; C.B. FLEET INVESTMENT CORPORATION
Reel/Frame 041102/0595 →
SECURITY INTEREST Recorded Oct 24, 2014
From: C. B. FLEET COMPANY, INCORPORATED; C.B. FLEET INVESTMENT CORPORATION
To: GCI CAPITAL MARKETS LLC, AS AGENT
Reel/Frame 034028/0363 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2014
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: C. B. FLEET COMPANY, INCORPORATED
Reel/Frame 034032/0851 →